Professor Dr. Rene Bernards - Gilde Healthcare

team
Venture&Growth

All team members
Professor Dr. Rene Bernards
Operational Partner
United States of America

Professor Dr. Rene Bernards

Operational Partner

Professor Dr René Bernards brings extensive experience in oncology as a researcher and a serial entrepreneur. He is a Professor at the Netherlands Cancer Institute (NKI). He performed his post-doctoral research at the Massachusetts Institute of Technology in Robert Weinberg’s group at the Whitehead Institute. He joined Harvard Medical School as an assistant professor in 1988 to study function of oncogenes and tumor suppressor genes He received his PhD in 1984 from the University of Leiden. In 1994 he was appointed part time professor of molecular carcinogenesis at Utrecht University, The Netherlands.

His laboratory focuses on the development of new tools to perform genome-wide genetic screens to identify novel genes that act in cancer relevant pathways.His research has produced 14 clinical trials (including 2 global Phase 3 trials).

He has co-founded Agendia in 2003, Prolifix in 1993 (currently TopoTarget) and Qameleon.

At Gilde he actively contributes his experience in drug target discovery, preclinical and clinical development and precision medicine in the evaluation of investment opportunities in oncology, company building and portfolio management.

Dan Secor

Associate Healthtech
Venture&Growth
Dan Secor joined Gilde Healthcare in 2020 in the Cambridge office and focuses on the Healthtech sector. He was part of Gilde’s investment team in Eargo, where he served as a board observer. Before joining...

Dr. Paul Parren

Operational Partner
Paul Parren is an internationally recognized antibody drug innovator and developer. Paul was Head of Preclinical Development and Research at Genmab (2002-2017), translating antibody biology successfully into immunotherapies from discovery to the clinic, including approved...

Arthur Franken

General Partner Healthtech/Therapeutics
Venture&Growth
Arthur Franken joined Gilde in 2001 and was part of the founding team of Gilde Healthcare. He is focusing on venture and growth capital investments in the biopharm, medtech, diagnostics and digital health sectors. He...